Clinical Practice Guideline for Hypertension: Evaluation and Analysis

This report provides a detailed analysis of a clinical practice guideline for hypertension, addressing the healthcare problem of high blood pressure and its impact on patient management. It examines the benefits of clinical practice guidelines, focusing on their role in optimizing patient care and improving treatment quality. The report identifies hypertension as a significant health concern, outlining its symptoms, effects, and prevalence in the US population. It reviews the evidence-based guidelines developed for managing high blood pressure, including recommendations from the Eighth Joint National Committee. The analysis covers the direction provided to healthcare providers, patient management strategies, healthcare needs, and the influence of changing demographics and healthcare policies. The report also explores the need for guideline revisions, strategies to increase the likelihood of guideline adherence, and an evaluation of the effectiveness of revised clinical practices. The conclusion emphasizes the importance of effective clinical practice guidelines in managing hypertension and improving patient outcomes.

RUNNING HEAD: CLINICAL PRACTICE GUIDELINE 0
HYPERTENSION

CLINICAL PRACTICE GUIDELINE 1
Table of Contents
Introduction......................................................................................................................................2
Healthcare problem identified.........................................................................................................2
Practice guideline.............................................................................................................................3
Clinical practice guideline...........................................................................................................3
Address Health problems.............................................................................................................4
Direction to healthcare provider..................................................................................................4
Patient Management....................................................................................................................5
Analysis...........................................................................................................................................5
Healthcare needs..........................................................................................................................5
Changing demographics..........................................................................................................6
Changes in healthcare policies.....................................................................................................6
Revision of Clinical Practice guideline.......................................................................................6
Changes in Clinical Practice guideline........................................................................................7
Changes in US demographics affect Clinical practice guideline.................................................7
Strategies to increase likelihood..................................................................................................7
Evaluation........................................................................................................................................8
Effectiveness of revised Clinical practice....................................................................................8
Conclusion.......................................................................................................................................9
References......................................................................................................................................10

CLINICAL PRACTICE GUIDELINE 2
Introduction
Clinical practice guidelines include recommendations intended to optimize patient care
that is informed by a systematic review of the evidence and an assessment of the benefits and
harms of alternative care options (Hypertension Clinical Guidelines, 2017). There are various
benefits of clinical practice guidelines which include improved quality and treatment which
healthcare providers give to the patients. Therefore, the estimation demonstrates that guideline
leads to increasing 60% efficiency and quality of the care. It is clear and concise as well as
different for diverse healthcare problems which majorities of the patients are facing in the US.
This allows healthcare providers to ensure safe practice and this increases consistency in the care
because it is provided in different ways.
This also helps in make coordination in the healthcare environment because of building
the knowledge among the staff members, since it helps in providing different treatments to the
variations of the patients (Schwartzbard, Newman, Weintraub, & Baum, 2018). In this report,
"Hypertension" is selected as the health problem and discussions are made on describing the
clinical practice guideline adopts to provide quality guidelines, effects of this on the patient's
management. The analysis is also done by describing a future patient's requirement and revision
of the guidelines. Further, evaluation is also done by investigating the effects of a revised clinical
practice guideline on efficiency.
Healthcare problem identified
Hypertension is refer to a common condition because in this situation the long term force
of the blood against the artery walls is very high, this situation is also called high blood pressure.
This disease has highly negative effects on the health of the patients which result in increasing
heart diseases. It is because the estimation demonstrates that in this condition, individual’s heart
pumps high level of blood and it also reduces the arteries which resulted in increasing the blood
pressure of the patients (Stout, et al., 2019). This disease damages the overall blood vessel of the
patient and it leads to several other diseases which include heart attack and other dangerous
diseases.

CLINICAL PRACTICE GUIDELINE 3
Hypertension problem increased in 2018 and affected the overall health of the patient in a
highly negative manner it is because the majority of the patients also suffered from other
dangerous diseases. The major symptoms of the disease include that this leads in increasing the
headache, nosebleeds and involves the patient in various other stages of threat which are highly
dangerous for the patients. This disease starts from the age of 18 and continues up to the age of
40 that this between the ages of 18-39, the patient is suffered from a high level of risk. The other
symptoms include severe headache, chest pain, blood in urine etc; therefore sometimes it is
considered silent-killer.
It is found that the morbidity of the disease describes that in adults with the age of 20
about 33.4% of the men are suffered from this problem and 30.7% are women in the US. This
result describes that high blood pressure increases with the rise in the year. The mortality rate
related to the high blood pressure demonstrates that this raise from 2005 that is in the year 2015
the death rate is increased by 79,000 due to high blood pressure. The epidemiology of
hypertension shows that it increases in female in comparison to the men which is 55% in the
females, however, several clinical guideline practices was developed to provide efficient
treatment (Stout, et al., 2019). It also examine that the pathophysiology of the disease revealed
that it is highly increased because of an increase in the consumption of potassium and sodium.
Therefore, this disease leads in increasing risk of other diseases which include kidney disease,
heart disease and various other problems this will increase the death rate of the patients who all
have the risk of hypertension. It is important to prevent hypertension because it leads in
preventing the patients from the heart disease and can also support them to prevent from other
dangerous diseases.
Practice guideline
Clinical practice guideline
Evidence-Based Guidelines are developed for Managing the High Blood Pressure and
Hypertension and it is develop through various members in the panel who all are selected in the
"Eight Joint National Committee". The clinically guidelines describe-

CLINICAL PRACTICE GUIDELINE 4
 The new clinical practice guideline is developed based on the increasing risk as well as
clinical trial experience.
SOURCE: (Hypertension Clinical Guidelines, 2017)
 It also analyzed that in the new clinical practice guidelines prevalence of hypertension
should be more than 14 percent using the proposed “SBP as well as DBP cut-points” for
the hypertension definition.
 The guideline also describes the secondary form of hypertension in which secondary
causes and reason of hypertension are mainly due to the high blood pressure in around 10
percent of the patients by hypertension.
 The new guideline also defined that blood pressure more than 130/80 mmHg is in the risk
of other dangerous diseases such as heart attack and stroke. Elevated BP is considered as
>120/80 mmHg (Hypertension Clinical Guidelines, 2017).
 The management of drugsdrugs in clinical practice guideline for hypertension is done by
using the medication of BP-lowering by adding "nonpharmacological interventions", this
is highly base on the BP patient has and the risk which the patient has because of
ASCVD.
 The current practice guidelines describe that special treatment was also given to the
patients for managing hypertension who all are also suffered from other diseases such as
chronic kidney disease, diabetes; valvular heart disease that is special treatment is
provided to these type of patients.
 The other consideration also affects the prevention of the adult from hypertension which
includes "the presence of hypertension in a resistant manner and hypertensive crises or
emergency".

CLINICAL PRACTICE GUIDELINE 5
 Clinical practice guideline also described that hypertension will be prevented by
receiving antihypertensive drug therapy.
The practice guideline is based on the current evidence and demonstrate that it is
important to prevent high blood pressure because it gives rise to other diseases such as strokes,
kidney disease, and heart attack. Further, the prevention lowers the high BP and support the
patient to protect other organs such as kidney damage, heart and brain.
"The United States Preventive Services Task Force Recommendation for Hypertension"
also recommends to does screening of the adults who all are equal to and more than the age of 40
years. This is also recommended to the patients, who all are suffering from high blood pressure,
it also recommended that patients are at higher risk which faced "high-normal blood pressure
that is 130 to 139/85 to 89 mm Hg" and those who all are obese as well as overweight.
Address Health problems
Through estimation it is revealed that high blood pressure still not reduced by developing
clinical practice guidelines it is because the estimation describes tat in the year 2018, the number
of hypertension patients increased by 32%. In my perception, It is less in comparison to the old
percentage that 46% but still does not reduce according to the expectation. There are about
higher than 100 million patients who are suffered from high blood pressure in the US.
The other infectious diseases among the patient are increased that is heart disease etc.
This does not improve the health of the patients in the US but the patient also influences through
other risk factors. This also results in increasing the death rate of the patients that is in 2018 in
comparison to the earlier year (Stout, et al., 2019).
Direction to healthcare provider
Clinical practice guideline is provided to the patient that is healthcare providers provide
adequate treatment so that blood pressure among the patient under and more the age of 60 will be
received. These guidelines also support the healthcare providers who all are having kidney
disease and through these kidney outcomes will be resolved and can also give the direction to the
patient up to which the BP will be reduced.

CLINICAL PRACTICE GUIDELINE 6
For this reason, equality and other issues will also be managed and prevented it is
because by this the patients get adequate treatment according to the age. Further, the treatment is
increased and provide guidelines for long term treatment so that adequate care is provided to the
patients and guidelines also provides maximum direction to the healthcare provider regarding the
quality treatment.
Patient Management
I found that clinical practice guideline is somewhat effective it is because this reduces the
number of hypertension patients but not in the same ratio. It is because in the year 2018, the
percentage of high blood pressure is 32%. This also increases the death rate due to increasing the
other dangerous diseases which affect in highly negative terms (Schwartzbard, Newman,
Weintraub, & Baum, 2018). The patients will also manage by getting adequate and quality
treatments according to capabilities and age group, but the patients do not prevent satisfactorily
according to the expectation.
According to me the patient will be managed more effectively when by providing the
benefits of the exercise and encourage them to exercise regularly it is because this can support
the patient in reducing their blood pressure. I also perceive there is also various other reason
through which by providing the information about the healthy diet which patient can take that is
getting whole grains, reducing the intake of sodium. The patient can also managed in more
effective manner by managing the level of stress and depression from the patients from whose
tension raise the blood pressure among them. The management can also be in more efficient
manner by monitoring the blood pressure in regular manner so that their treatment will be
improved.
Analysis
Healthcare needs
I perceive that the needs of the patients are to get quality antihypertensive medication
which can manage the stress and provide positive effects to the patients. The estimation
demonstrates that these medications lead in providing quality treatment to the patients and
safeguard the patients from the long term harm from the drugs.

CLINICAL PRACTICE GUIDELINE 7
According to me the other requirements of the patients are that healthcare providers have
to provide plan to the patients for losing their weight and to get potential benefits to the patients.
The future needs of the patients are estimated that in US majority of the hypertension patients
has also suffered from the problem of obesity.
Changing demographics
I also examine that that due to change in the age every patient wants drugs and
medications through certain changes which is clearly described in the clinical practice guidelines
that each age group patient with a different disease in addition to hypertension will receive
different treatment and medications. The patients also get quality treatments due to increase in
the income that is their needs are to get specialized treatment so that BP will be low in the long
run.
Changes in healthcare policies
In my perception, the healthcare policies are changed for the patients who are suffered
from the high blood pressure disease that is it increases the public programs which is mainly for
the low-income group patients of the US. So that they can gain awareness about the things, diet
plan and activities which is to be followed for reducing the high blood pressure, this program is
developed to provide knowledge and medications according to the age and their needs. This is
because if the patient makes intake of more sodium the treatment will be accordingly so that their
blood pressure will be managed (Stout, et al., 2019).
Revision of Clinical Practice guideline
Yes, the clinical practice guideline needs revision it is because this does not provide
efficient results according to the expectation. This is due to the reason that in the current year
hypertension patients are more that is 32% and death rate of the population between the ages of
18-69 is also raised. In my opinion the revision will be made by considering more disease that is
the estimation describes that number of patient which are suffering from hypertension is also
faced from other dangerous problems such as obesity and cardiovascular disease (Schwartzbard,
Newman, Weintraub, & Baum, 2018). Therefore, I also perceive that the revision guidelines can
be made by considering these disease and needs of the patients. This is the main issue in the US
it is because due to hypertension the patients also faced through heart disease, which also

CLINICAL PRACTICE GUIDELINE 8
requires other additional strategies which panel member can adopt to develop new or revision of
the clinical practice guidelines.
Changes in Clinical Practice guideline
If I will make changes in the clinical practice guidelines I could make the guidelines by
targeting the BP in different subsets which includes more than equal to 65-year patient should
have BP up to greater than 130/80. The changes can also make in the grading of hypertension
that is for grade 2 it should be less than 140/90 (Stout, et al., 2019). Further, the revision in the
practices is made due to describing the strategies for healthcare provider so that they can
efficiently manage the patient of hypertension by adopting of losing their weight and by dividing
the diseases by adding their dangerous disease with hypertension. This can help in providing
accurate treatment and overcome the problem to solving the issue of patient management in the
healthcare organization of US.
Changes in US demographics affect Clinical practice guideline
According to me the change in the US demographics and healthcare reform affects the
clinical practice guideline it s because of change in the age that is the majority of the age group
which are suffered from hypertension influence the panel member to change the treatment and
target BP. The healthcare reform increases the policy in US to change the target BP to the
patients which are less than and equal to the age of 69. It is because at this age it is difficult and
dangerous for the patient to get the treatment due to various other health problems. Therefore the
estimation revealed that this is influenced in highly negative manner.
Strategies to increase likelihood
I will make the strategies and practices in the form of policies so that it becomes
regulatory for clinical practice to include this in providing treatment to the patients which are
diagnosed through hypertension that is high blood pressure. I will also spread awareness about
educating the clinics to used the new guidelines by providing them the knowledge about the
effects this leads in increasing the likelihood and raising the abilities to understand the healthcare
problem of the patient in efficient manner. Further, I could also take the feedback from the
patients regarding the new guidelines so that their opinion will be recorded and given to the
healthcare organization about clinical practice which can raise the likelihood. I would also

CLINICAL PRACTICE GUIDELINE 9
describe the effectiveness of the revised practice through the practical appliance. So that it can
increase and improve the treatment to the patients by directing the healthcare providers
(Schwartzbard, Newman, Weintraub, & Baum, 2018).
Evaluation
Effectiveness of revised Clinical practice
In my opinion, there are various steps which to be followed while determining the
effectiveness of the revised clinical practice guideline in directing care for patients for
hypertension which includes:-
 Identifying the background information about the patients that is if the revised solution is
according to the health problems of the patient it is because the estimation demonstrates
that more patients in the US are suffered from hypertension with various other diseases.
In this further research is conducted to understand the same practice which earlier being
their outcomes in the long run. Through can I can get information about the accuracy and
effectiveness of the clinical practice in providing care to the patients (Stout, et al., 2019).
 The next step best research which is related to the chosen clinical practice it is because
through this it will provide the knowledge about the effectiveness and give knowledge to
the clinical practice bout the efficiency of the revised and new clinical practice.
 After reading and getting the information about the effectiveness of the clinical practice,
further appraisal and evaluation is done by applying the clinical guideline more
practically. This step is done because by determining the applicability of this practice
through applying in the healthcare organization. Through this evaluation regarding
quality care is recorded and quality of the guidelines is determined by satisfying patients
and through their prevention in managing hypertension that is high blood pressure (Stout,
et al., 2019).
 After, application the results received about the effectiveness in the revised practice will
be recorded and summarize so that the gap will be identified. In my opinion, the revised
practice is effective but if any deviation arises in this step some changes will be
according to the requirements. This can overcome the problem of changes in the
demographics and clinical reform in the US.

CLINICAL PRACTICE GUIDELINE 10
 I believe that the more prevention and efficient management leads in providing better
outcomes and through which effectiveness will be identified and describes that critical
practice will be effective because of including needs of the patients and including the
previous guideline made by panel members. This can support the healthcare providers in
providing directions to the treatments for adults which are faced high blood pressure and
results in providing quality care to the patients (Schwartzbard, Newman, Weintraub, &
Baum, 2018). In US hypertension is increased it is because various initiatives are taken to
support and to reduce the number of patients which are having this problem.
Conclusion
From the above, it is concluded that majority of the adults are suffering from
hypertension due to various reason and through this various clinical practice guidelines are
developed. As, less than and equal to 60 age population will receive treatment to decrease BP up
to “systolic BP (SBP) ≥ 150 mmHg”, etc. The estimation describes that these guidelines do not
provide efficient results to the patients and still most of the patients are facing high blood
pressure in the US which can give rise to several other infectious and dangerous diseases. This
guideline also provides direction to the healthcare providers for managing the patient but still the
needs of the patients' changes due to alterations in the demographics and healthcare reforms.
The clinical practice guideline should be revised because of reducing in the negative
effects and raise prevent the patients from hypertension that changes in the targeting, for 65-year
patients the BP could be greater than "130/80". The different ages and policies affect the clinical
practice guidelines and for this strategy of getting feedback from the patient about efficient
guidelines, awareness is adopted so that guidelines will be accepted by clinical practices. The
revised guidelines are highly effective it is because this healthcare provider will get direction
more efficiently in identifying the hypertension disease among patients. This is done by adopting
the steps of applying the disease more practically to understand the quality and specialization in
the treatment.

CLINICAL PRACTICE GUIDELINE 11
References
Hypertension Clinical Guidelines. (2017). Retrieved from American Health Association:
https://healthmetrics.heart.org/wp-content/uploads/2017/11/Top-10-Things-to-Know.pdf
Schwartzbard, A. Z., Newman, J. D., Weintraub, H. S., & Baum, S. J. (2018). The 2017 high blood
pressure clinical practice guideline: The old and the new. Clinical cardiology , 41 (3), 279.
Stout, K. K., Daniels, C. J., Aboulhosn, J. A., Bozkurt, B., Broberg, C. S., Colman, J. M., et al. (2019).
Guideline for the management of adults with congenital heart diseaseTask Force on Clinical
Practice Guidelines. Circulation , 139 (14), 637-697.